AlzChem Group AG (ACT) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.083x

Based on the latest financial reports, AlzChem Group AG (ACT) has a cash flow conversion efficiency ratio of 0.083x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€21.52 Million ≈ $25.15 Million USD) by net assets (€258.23 Million ≈ $301.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

AlzChem Group AG - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how AlzChem Group AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ACT liabilities breakdown for a breakdown of total debt and financial obligations.

AlzChem Group AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of AlzChem Group AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Zhuhai Orbita Control Eng
SHE:300053
0.011x
AOZORA BANK LTD ADR/20
F:AON0
N/A
Rogers Corporation
NYSE:ROG
0.039x
Lao Feng Xiang Co Ltd A
SHG:600612
-0.154x
Redington Limited
NSE:REDINGTON
0.078x
Shandong Sacred Sun Power Sources Co Ltd
SHE:002580
0.017x
Dongguan Eontec Co Ltd
SHE:300328
-0.045x
Silicon2 Co. Ltd.
KQ:257720
0.069x

Annual Cash Flow Conversion Efficiency for AlzChem Group AG (2012–2025)

The table below shows the annual cash flow conversion efficiency of AlzChem Group AG from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see ACT company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €258.23 Million
≈ $301.90 Million
€137.01 Million
≈ $160.18 Million
0.531x +4.69%
2024-12-31 €207.47 Million
≈ $242.56 Million
€105.15 Million
≈ $122.93 Million
0.507x +14.07%
2023-12-31 €163.56 Million
≈ $191.22 Million
€72.67 Million
≈ $84.96 Million
0.444x +1629.37%
2022-12-31 €145.95 Million
≈ $170.63 Million
€-4.24 Million
≈ $-4.96 Million
-0.029x -106.05%
2021-12-31 €89.56 Million
≈ $104.71 Million
€43.02 Million
≈ $50.29 Million
0.480x -32.30%
2020-12-31 €68.66 Million
≈ $80.27 Million
€48.71 Million
≈ $56.95 Million
0.709x -0.24%
2019-12-31 €61.35 Million
≈ $71.72 Million
€43.63 Million
≈ $51.01 Million
0.711x +40.35%
2018-12-31 €68.39 Million
≈ $79.96 Million
€34.66 Million
≈ $40.52 Million
0.507x -4.33%
2017-12-31 €57.89 Million
≈ $67.68 Million
€30.66 Million
≈ $35.85 Million
0.530x --
2016-12-31 €0.00
≈ $0.00
€-36.08K
≈ $-42.18K
x --
2015-12-31 €0.00
≈ $0.00
€-49.19K
≈ $-57.50K
x --
2014-12-31 €0.00
≈ $0.00
€140.11
≈ $163.80
x --
2013-12-31 €1.94K
≈ $2.27K
€15.57 Million
≈ $18.21 Million
8036.636x +243.97%
2012-12-31 €8.86K
≈ $10.36K
€20.71 Million
≈ $24.21 Million
2336.416x --

About AlzChem Group AG

XETRA:ACT Germany Specialty Chemicals
Market Cap
$1.96 Billion
€1.68 Billion EUR
Market Cap Rank
#6621 Global
#966 in Germany
Share Price
€165.90
Change (1 day)
-4.71%
52-Week Range
€118.60 - €188.10
All Time High
€287.60
About

AlzChem Group AG, together with its subsidiaries, develops, produces, and markets a range of chemical specialties in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The Specialty Chemicals segment sells specialty chemical products that are used in the chemical, f… Read more